RISING PHARMA HOLDINGS, INC. Citalopram Import Data from India (DGFT 2022–2026)

Q: Who are the top buyers of Citalopram from India and how much does RISING PHARMA HOLDINGS, INC. import?

India exports Citalopram to 736 buyers globally worth $54.8M. RISING PHARMA HOLDINGS, INC. imports $3.5M (1.2% market share) with 194 shipments from UNITED STATES.

Q: What is the average order value for RISING PHARMA HOLDINGS, INC.'s Citalopram imports?

RISING PHARMA HOLDINGS, INC.'s average Citalopram order value is $18.2K per consignment, based on 194 shipments totaling $3.5M.

Q: Who supplies Citalopram to RISING PHARMA HOLDINGS, INC.?

RISING PHARMA HOLDINGS, INC. sources Citalopram from 2 verified suppliers: GRAVITI PHARMACEUTICALS PRIVATE LIMITED ($3.5M, 98.2%), AUROBINDO PHARMA LIMITED ($63.1K, 1.8%). Based on 194 customs records.

Q: How does RISING PHARMA HOLDINGS, INC. compare to other Citalopram importers?

RISING PHARMA HOLDINGS, INC. ranks #13 among 736 Citalopram importers from India with 1.2% market share and 194 shipments.

Q: Who are the top Citalopram importers from India?

Top Citalopram importers: YUSEN LOGISTICS BENELUX BELGIUM ($8.9M), TORRENT PHARMA INC ($7.3M), LEK S.A. ($4.1M), AUROLOGISTICS LLC (AUROBINDO PHARMA ($3.9M), CIPLA MAROC ($3.5M).

Suresh Sormare

Citalopram

India Pharmaceutical Trade Intelligence

$254.5M257 Suppliers101 CountriesHS 30049099

ExportsIndia → MOROCCO31.6%India → UNITED STATES28.8%

ImportsCANADA → India$5.3M UNITED STATES → India$24.9K

#1 Supplier: MEDISPRAY LABORATORIES #1 Buyer: CIPLA MAROC

RISING PHARMA HOLDINGS, INC. — Citalopram Importer #13 | $3.5M Trade Value | TransData Nexus | TransData Nexus

RISING PHARMA HOLDINGS, INC. — Citalopram Importer Profile

Pharmaceutical Importer · #13 buyer for Citalopram · $3.5M import value · 194 shipments · UNITED STATES · DGFT Verified

RISING PHARMA HOLDINGS, INC. is the #13 importer of Citalopram from India with $3.5M in import value and 194 verified shipments. RISING PHARMA HOLDINGS, INC. holds a 1.2% market share in Citalopram imports based in UNITED STATES. The company sources from 2 verified suppliers across 126 formulations shipped to 1 country. Overall, RISING PHARMA HOLDINGS, INC. imports 18 pharmaceutical products worth $87.0M across 11 therapeutic categories.

RISING PHARMA HOLDINGS, INC. — Citalopram Import Profile: Suppliers, Formulations & Sources

RISING PHARMA HOLDINGS, INC. — Citalopram import analysis from Indian Customs (DGFT) data.

Who Actually Supplies Citalopram to RISING PHARMA HOLDINGS, INC.?

Verified from 194 customs shipment records

Supplier	Value	Shipments	% Share
GRAVITI PHARMACEUTICALS PRIVATE LIMITED	$3.5M	190	98.2%
AUROBINDO PHARMA LIMITED	$63.1K	4	1.8%

RISING PHARMA HOLDINGS, INC. sources Citalopram from 2 verified Indian suppliers based on 194 customs records. The primary supplier is GRAVITI PHARMACEUTICALS PRIVATE LIMITED accounting for 98.2% of imports.

How Does RISING PHARMA HOLDINGS, INC. Compare to Nearest Citalopram Importers?

Buyers ranked immediately above and below #13 by import value

#	Buyer	Country	Import Value	Shipments	Avg/Shipment
11	MYLAN PHARMACEUTICALS INC,	UNITED STATES	$3.5M	75	$47.0K
12	WAYMADE PLC	UNITED KINGDOM	$3.2M	64	$50.0K
13	RISING PHARMA HOLDINGS, INC. ★	UNITED STATES	$3.1M	174	$18.0K
10	AUROLOGISTICS LLC	UNITED STATES	$3.0M	60	$50.0K
3	MYLAN PHARMACEUTICALS INC	UNITED STATES	$2.7M	54	$50.0K

Where Does RISING PHARMA HOLDINGS, INC. Import Citalopram To?

Destination countries from 194 verified shipments

Country	Value	Shipments	Share
UNITED STATES	$3.5M	194	100.0%

RISING PHARMA HOLDINGS, INC. imports Citalopram to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $3.5M.

What Citalopram Formulations Does RISING PHARMA HOLDINGS, INC. Import?

Formulation	Value	Shipments
ESCITALOPRAM TABLETS USP 10MG (29888X100'S) (BATCH NOS: ECB125004D)	$41.1K	1
ESCITALOPRAM TABLETS USP 10MG (29760X100'S)(BATCH NOS: ECB125005D)	$40.9K	1
ESCITALOPRAM TABLETS USP 10 MG (29504X100'S) (BATCH NOS: ECB125006D)	$40.5K	1
ESCITALOPRAM TABLETS USP 10 MG (29440X100'S) (BATCH NOS: ECB225007D)	$40.5K	1
ESCITALOPRAM TABLETS USP 10MG (29120X100'S)(BATCH NOS: ECB125009D)	$40.1K	1
ESCITALOPRAM TABLETS USP 10MG (28416X100'S)(BATCH NOS: ECB125003D)	$39.0K	1
ESCITALOPRAM TABLETS USP 10MG (3060X1000S)(BATCH NO.ECB124039G)	$35.2K	3
ESCITALOPRAM TABLETS USP 10MG (3049X1000S)(BATCH NO.ECB124040G)	$35.0K	3
ESCITALOPRAM TABLETS USP 10MG (3038X1000S)(BATCH NO.ECB124038G)	$34.9K	3
ESCITALOPRAM TABLETS USP 10MG (3034X1000'S)(BATCH NO: ECB124066G)	$34.9K	3

RISING PHARMA HOLDINGS, INC. imports 126 distinct Citalopram formulations from India. The top formulation is ESCITALOPRAM TABLETS USP 10MG (29888X100'S) (BATCH NOS: ECB1 with 1 shipments worth $41.1K.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Citalopram shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
2.Buyer Identification: RISING PHARMA HOLDINGS, INC. matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
4.Market Share: Calculated as RISING PHARMA HOLDINGS, INC.'s capped import value divided by total capped export value for Citalopram across all Indian exporters.
5.Verified Records: This page is backed by 194 individual customs records matching RISING PHARMA HOLDINGS, INC. importing Citalopram, covering 126 formulations from 2 verified suppliers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 101+ countries, 736+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Citalopram

Citalopram

RISING PHARMA HOLDINGS, INC. — Citalopram Importer Profile

RISING PHARMA HOLDINGS, INC. — Citalopram Import Profile: Suppliers, Formulations & Sources

Who Actually Supplies Citalopram to RISING PHARMA HOLDINGS, INC.?

How Does RISING PHARMA HOLDINGS, INC. Compare to Nearest Citalopram Importers?

Where Does RISING PHARMA HOLDINGS, INC. Import Citalopram To?

What Citalopram Formulations Does RISING PHARMA HOLDINGS, INC. Import?

Regulatory Requirements: Importing Citalopram into United States

Regulatory Authority

Approval Process for Generic Citalopram

GMP Requirements

Import Licence & Documentation

Labeling & Packaging

Who Are the Top Buyers of Citalopram from India and How Much Does RISING PHARMA HOLDINGS, INC. Import?

What Is the Average Order Value for RISING PHARMA HOLDINGS, INC.'s Citalopram Imports?

Who Supplies Citalopram to RISING PHARMA HOLDINGS, INC.?

How Does RISING PHARMA HOLDINGS, INC. Compare to Other Citalopram Importers?

What Other CNS & Psychiatric Products Does RISING PHARMA HOLDINGS, INC. Import?

About RISING PHARMA HOLDINGS, INC.

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Citalopram Import Data for RISING PHARMA HOLDINGS, INC.

RISING PHARMA HOLDINGS, INC. × Citalopram

Company Overview

Top Products by RISING PHARMA HOLDINGS, INC.

Related Analysis

Need Detailed Import Data?

Data Source